Top-News
Freitag,
25.08.2017 22:00
von
PR Newswire
| Aufrufe: 74
PETS Investor Alert: Hagens Berman Alerts Investors in PetMed Express of Investigation into Possible Securities Law Violations
Ein Business-Meeting (Symbolbild).
© gilaxia / E+ / Getty Images
PR Newswire
SAN FRANCISCO, Aug. 25, 2017
SAN FRANCISCO, Aug. 25, 2017 /PRNewswire-USNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in PetMed Express, Inc. (NASDAQ: PETS) to the firm's investigation into possible securities law violations in response to alleged improper opioid sales.
If you purchased or otherwise acquired securities of PetMed before August 23, 2017 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
or contact Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000 or emailing PETS@hbsslaw.com.
On August 23, 2017, a blog post by Aurelius Value entitled "PetMed: Exploiting America's Opioid Epidemic" raised several critical questions about PetMed. More specifically, Aurelius alleged PetMed has been targeting the sale of opioid medication like tramadol to individuals, not just pet owners for the pets themselves.
This post drove the price of PetMed shares down $3.19, or about 8% on heavy volume, to close at $36.22 on August 23, 2017.
On August 24, 2017, Benzinga reported ads for PetMed's tramadol were removed from Alphabet Inc.'s Google searches.
"We're investigating the merits of Aurelius' allegations and, if true, the damages suffered by PetMed investors," said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding PetMed should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email PETS@hbsslaw.com.
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact:
Reed Kathrein, 510-725-3000
View original content with multimedia:http://www.prnewswire.com/news-releases/pets-investor-alert-hagens-berman-alerts-investors-in-petmed-express-of-investigation-into-possible-securities-law-violations-300509494.html
SOURCE Hagens Berman Sobol Shapiro LLP
Werbung
Mehr Nachrichten zur Petmed Express Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
-1
Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
